Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Compugen Ltd (NQ: CGEN )

1.750 -0.120 (-6.42%)
Streaming Delayed Price Updated: 11:31 AM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,998
Open 1.900
Bid (Size) 1.750 (2)
Ask (Size) 1.760 (4)
Prev. Close 1.870
Today's Range 1.750 - 1.900
52wk Range 0.5300 - 3.030
Shares Outstanding 86,433,432
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024
CGEN stock results show that Compugen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
CGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023
CGEN stock results show that Compugen missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
-12.28%
-12.28%
1 Month
-5.91%
-5.91%
3 Month
-6.91%
-6.91%
6 Month
-9.33%
-9.33%
1 Year
+42.28%
+42.28%

More News

Read More
Earnings Scheduled For March 5, 2024
Via Benzinga
Earnings Preview For Compugen
Via Benzinga
7 Speculative Stocks to Double Your Money THIS Year
Via InvestorPlace
Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
5 Analysts Have This to Say About Compugen
Via Benzinga
Compugen Earnings Preview
Via Benzinga
Expert Ratings for Compugen
Via Benzinga
Compugen: Q1 Earnings Insights
Via Benzinga
Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Compugen Ltd. (NASDAQ: CGEN) is One of Tuesday Morning’s Most Active Stocks
Via Investor Brand Network
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
Via Benzinga
Why Are Stocks Up Today?
Via InvestorPlace
Why Is Compugen (CGEN) Stock Up 189% Today?
Via InvestorPlace
US Stocks Higher; Accenture Issues Weak Sales Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
From Gilead Sciences, Inc.
Via Business Wire
7 Promising Penny Stocks With the Potential to Defy Expectations
Via InvestorPlace
Use Support And Resistance Levels To Avoid Chaos In Your Portfolio
Via Talk Markets
Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN
Via AB Newswire
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
Why Compugen Shares Are Up Today
Via The Motley Fool
Earnings Scheduled For February 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.